Brenntag AG (OTCMKTS:BNTGY – Get Free Report) saw a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 2,751 shares, a drop of 73.1% from the August 31st total of 10,215 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 21,540 shares, the days-to-cover ratio is presently 0.1 days.
Brenntag Stock Performance
BNTGY stock traded down $0.01 during midday trading on Monday, reaching $13.55. 5,154 shares of the company traded hands, compared to its average volume of 38,693. The firm has a market capitalization of $9.79 billion, a price-to-earnings ratio of 22.97 and a beta of 0.63. Brenntag has a 52-week low of $10.19 and a 52-week high of $14.97. The business has a 50 day moving average of $14.02 and a 200-day moving average of $13.41.
Brenntag (OTCMKTS:BNTGY – Get Free Report) last released its earnings results on Wednesday, August 12th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.04. Brenntag had a return on equity of 8.30% and a net margin of 2.41%.The firm had revenue of $4.96 billion for the quarter, compared to the consensus estimate of $4.66 billion. Research analysts anticipate that Brenntag will post 0.85 earnings per share for the current year.
Wall Street Analyst Weigh In
View Our Latest Research Report on Brenntag
About Brenntag
Brenntag SE is a Germany-based chemical distribution company that supplies industrial and specialty chemicals to customers in a broad range of industries. Its product portfolio includes solvents, acids, gases, solvents, additives, and other chemical raw materials used in sectors such as manufacturing, water treatment, food and nutrition, pharmaceuticals, personal care, agriculture, and energy.
The company operates through two principal business areas: Essentials, which focuses on widely used industrial chemicals, and Specialties, which provides higher-value chemicals and application-specific solutions.
Recommended Stories
- Five stocks we like better than Brenntag
- 2 China-Focused ETFs For After the Trump-Xi Summit
- 3 Dividend Stocks Investors May Be Missing in 2026
- 3 Healthcare Stocks Showing Why the Sector Still Has Momentum
- Akamai’s Anthropic Deal Puts $5.5 Billion Behind Its Edge AI Pivot
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
